Form 4: Penumbra Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Penumbra Inc. Director Thomas Wilder sold 186 shares of common stock for $310.72 per share as part of a pre-arranged Rule 10b5-1 trading plan.
Summary
- Thomas Wilder, a Director of Penumbra Inc., sold 186 shares of the company's common stock.
- The transaction occurred on January 2, 2026, at a price of $310.72 per share.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan.
- Following this transaction, Thomas Wilder directly owns 0 shares and indirectly owns 4,506 shares through the Thomas and Catharine Wilder Family Trust.
Sentiment
Score: 5
Explanation: Neutral. The sale is a routine insider transaction conducted under a pre-arranged 10b5-1 plan, which mitigates any negative sentiment typically associated with insider selling.
Positives
- The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on new, non-public information.
Negatives
- A director selling shares, even under a 10b5-1 plan, can sometimes be perceived as a slight negative signal regarding management's confidence, though the impact is mitigated by the plan.
Future Outlook
NA
Industry Context
This is a routine insider transaction filing and does not provide specific industry context or trends. It reflects an individual director's pre-planned stock sale rather than a broader company or industry event.
Related Party Transactions
- The 4,506 shares indirectly owned by Thomas Wilder are held by the Thomas and Catharine Wilder Family Trust dated March 31, 2006, which is considered a related party.
Stakeholder Impact
- Minimal direct impact on shareholders as this is a routine, pre-planned insider sale. The transaction's small size relative to the company's market capitalization is unlikely to significantly affect overall market sentiment or company operations.
Key Dates
| Date | Description |
|---|---|
| 2006-03-31 | Date of the Thomas and Catharine Wilder Family Trust. |
| 2026-01-02 | Date of the common stock transaction (sale). |
| 2026-01-06 | Date the Form 4 was signed by attorney-in-fact. |
Recommendation
holdThis Form 4 filing details a routine, pre-scheduled sale of a small number of shares by a director under a 10b5-1 plan. Such transactions are generally not indicative of a change in company fundamentals or management's long-term outlook. Therefore, it does not provide sufficient new information to warrant a change from a 'hold' position based solely on this filing.
Keywords
Penumbra Inc, PEN, Form 4, Insider Trading, Stock Sale, Director, Thomas Wilder, 10b5-1 Plan, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.